Saarma M - Search Results

1

Current disease modifying approaches to treat Parkinson's disease.

Lindholm D, Mäkelä J, Di Liberto V, Mudò G, Belluardo N, Eriksson O, Saarma M. Lindholm D, et al. Among authors: saarma m. Cell Mol Life Sci. 2016 Apr;73(7):1365-79. doi: 10.1007/s00018-015-2101-1. Epub 2015 Nov 30. Cell Mol Life Sci. 2016. PMID: 26616211 Free PMC article. Review.

2

Neurotrophic factors in the auditory periphery.

Qun LX, Pirvola U, Saarma M, Ylikoski J. Qun LX, et al. Among authors: saarma m. Ann N Y Acad Sci. 1999 Nov 28;884:292-304. doi: 10.1111/j.1749-6632.1999.tb08649.x. Ann N Y Acad Sci. 1999. PMID: 10842601

3

Functional characterization of two splice variants of rat bad and their interaction with Bcl-w in sympathetic neurons.

Hamnér S, Arumäe U, Li-Ying Y, Sun YF, Saarma M, Lindholm D. Hamnér S, et al. Among authors: saarma m. Mol Cell Neurosci. 2001 Jan;17(1):97-106. doi: 10.1006/mcne.2000.0905. Mol Cell Neurosci. 2001. PMID: 11161472

4

GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway.

Yu LY, Jokitalo E, Sun YF, Mehlen P, Lindholm D, Saarma M, Arumae U. Yu LY, et al. Among authors: saarma m. J Cell Biol. 2003 Dec 8;163(5):987-97. doi: 10.1083/jcb.200305083. Epub 2003 Dec 1. J Cell Biol. 2003. PMID: 14657232 Free PMC article.

5

GDNF family receptor complexes are emerging drug targets.

Bespalov MM, Saarma M. Bespalov MM, et al. Among authors: saarma m. Trends Pharmacol Sci. 2007 Feb;28(2):68-74. doi: 10.1016/j.tips.2006.12.005. Epub 2007 Jan 10. Trends Pharmacol Sci. 2007. PMID: 17218019 Review.

6

MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain.

Lindholm P, Peränen J, Andressoo JO, Kalkkinen N, Kokaia Z, Lindvall O, Timmusk T, Saarma M. Lindholm P, et al. Among authors: saarma m. Mol Cell Neurosci. 2008 Nov;39(3):356-71. doi: 10.1016/j.mcn.2008.07.016. Epub 2008 Jul 30. Mol Cell Neurosci. 2008. PMID: 18718866

7

Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease.

Voutilainen MH, Bäck S, Pörsti E, Toppinen L, Lindgren L, Lindholm P, Peränen J, Saarma M, Tuominen RK. Voutilainen MH, et al. Among authors: saarma m. J Neurosci. 2009 Jul 29;29(30):9651-9. doi: 10.1523/JNEUROSCI.0833-09.2009. J Neurosci. 2009. PMID: 19641128 Free PMC article.

8

Thyroxin regulates BDNF expression to promote survival of injured neurons.

Shulga A, Blaesse A, Kysenius K, Huttunen HJ, Tanhuanpää K, Saarma M, Rivera C. Shulga A, et al. Among authors: saarma m. Mol Cell Neurosci. 2009 Dec;42(4):408-18. doi: 10.1016/j.mcn.2009.09.002. Epub 2009 Sep 16. Mol Cell Neurosci. 2009. PMID: 19765661

9

Persephin signaling through GFRalpha1: the potential for the treatment of Parkinson's disease.

Sidorova YA, Mätlik K, Paveliev M, Lindahl M, Piranen E, Milbrandt J, Arumäe U, Saarma M, Bespalov MM. Sidorova YA, et al. Among authors: saarma m. Mol Cell Neurosci. 2010 Jul;44(3):223-32. doi: 10.1016/j.mcn.2010.03.009. Epub 2010 Mar 27. Mol Cell Neurosci. 2010. PMID: 20350599

10

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.

Domanskyi A, Saarma M, Airavaara M. Domanskyi A, et al. Among authors: saarma m. Hum Gene Ther. 2015 Aug;26(8):550-9. doi: 10.1089/hum.2015.065. Hum Gene Ther. 2015. PMID: 26176331 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page